IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 141 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.41 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $962,593 | -46.6% | 211,559 | -17.4% | 0.00% | -40.0% |
| Q2 2023 | $1,802,655 | -20.5% | 256,059 | -31.0% | 0.01% | -28.6% |
| Q1 2023 | $2,267,170 | +34898.0% | 371,059 | -63.5% | 0.01% | -73.1% |
| Q4 2022 | $6,478 | -99.9% | 1,015,738 | +3.5% | 0.03% | -31.6% |
| Q3 2022 | $9,405,000 | -64.3% | 981,284 | -57.3% | 0.04% | -17.4% |
| Q2 2022 | $26,340,000 | +6831.6% | 2,298,802 | +19056.7% | 0.05% | +4500.0% |
| Q1 2021 | $380,000 | +38.2% | 12,000 | +20.0% | 0.00% | 0.0% |
| Q2 2020 | $275,000 | -69.1% | 10,000 | -89.1% | 0.00% | -75.0% |
| Q1 2019 | $891,000 | +65.6% | 91,392 | +50.1% | 0.00% | +100.0% |
| Q4 2018 | $538,000 | – | 60,880 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,222,701 | $25,005,000 | 8.92% |
| Broadfin Capital, LLC | 4,894,361 | $55,062,000 | 8.10% |
| GREAT POINT PARTNERS LLC | 3,496,340 | $39,334,000 | 6.13% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $24,619,000 | 4.51% |
| Prosight Management, LP | 715,317 | $8,047,000 | 4.49% |
| Avoro Capital Advisors LLC | 8,662,720 | $97,456,000 | 4.48% |
| QVT Financial LP | 821,361 | $8,748,000 | 2.26% |
| Perceptive Advisors | 7,290,199 | $82,014,000 | 2.19% |
| Rhenman & Partners Asset Management AB | 1,290,495 | $14,518,000 | 1.46% |
| EMORY UNIVERSITY | 185,915 | $2,092,000 | 1.37% |